Author

K. Beguir

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 1 Approach:diffusion model· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Research Focus:protein design· 1 Assay:protein structure· 1 Research Focus:protein structure prediction· 1 Assay:proteomics· 1

Frequent Co-Authors

U. Sahin· 2 shared Y. Fu· 2 shared A. Leach· 1 shared A. Muik· 1 shared A. Poran· 1 shared A. Toker· 1 shared A. Tovchigrechko· 1 shared B. G. Lui· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

U. Sahin

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

FrameDiPT: SE(3) Diffusion Model for Protein Structure Inpainting

C. Zhang, A. Leach, T. Makkink, M. Arbesu, I. Kadri, D. Luo, L. Mizrahi, S. Krichen, M. Lang, A. Tovchigrechko, N. Lopez Carranza, U. Sahin, K. Beguir, M. Rooney, Y. Fu

FrameDiPT is a diffusion model for protein structure inpainting that recovers masked sections using sequence and structural context, achieving comparable accuracy to existing models with limited data.

bioRxiv · Nov 21, 2023 · PreprintImmunology

Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T-cell recognition epitopes

A. Muik, B. G. Lui, H. Diao, Y. Fu, M. Bacher, A. Toker, J. Grosser, O. Ozhelvaci, K. Grikscheit, S. Hoehl, N. Kohmer, Y. Lustig, G. Regev-Yochay, S. Ciesek, K. Beguir, , U. Sahin

The paper examines how Omicron sublineages evade neutralizing antibodies but retain T-cell epitopes, suggesting T-cell immunity remains effective against these variants.

bioRxiv · Dec 15, 2022 · PreprintImmunology